CD274 and non-small cell lung carcinoma: In addition, CD274 loss has been associated with shorter OS to ICI blockade in non-squamous NSCLC as evaluated in Lamberti et al19 Similarly, in our study, the CD274 loss cohort trended toward a lower mOS when compared with the rest.